Journal
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS
Volume 15, Issue 9, Pages 1079-1091Publisher
BENTHAM SCIENCE PUBL
DOI: 10.2174/1871527315666160915112210
Keywords
Blood-brain barrier; brain diseases; central nervous system; liposomes; nanomedicine; nanoparticles
Categories
Ask authors/readers for more resources
The research of efficacious non-invasive therapies for the treatment of brain diseases represents a huge challenge, as people affected by disorders of the central nervous system (CNS) will significantly increase. Moreover, the blood-brain barrier is a key factor in hampering a number of effective drugs to reach the CNS. This review is therefore focusing on possible interventions of nanomedicine-based approaches in selected diseases affecting the CNS. A wide overview of the most outstanding results on preclinical evaluations of the potential of nanomedicine in brain diseases (i.e. brain tumor, Alzheimer, Parkinson, epilepsy and others) is given, with highlights on the data with relevant interest and real possibility in translation from bench-to-bedside. Moreover, a critical evaluation on the rationale in planning nanosystems to target specific brain pathologies is described, opening the path to a more structured and pathology-tailored design of nanocarriers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available